BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25646328)

  • 21. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.
    Wang CW; Lin HY; Shin SJ; Yu ML; Lin ZY; Dai CY; Huang JF; Chen SC; Li SS; Chuang WL
    Liver Int; 2011 Oct; 31(9):1326-31. PubMed ID: 21745282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between rs10830962 polymorphism in MTNR1B and lifestyle intervention on maternal and neonatal outcomes: secondary analyses of the DALI lifestyle randomized controlled trial.
    van Poppel MNM; Corcoy R; Hill D; Simmons D; Mendizabal L; Zulueta M; Simon L; Desoye G;
    Am J Clin Nutr; 2022 Feb; 115(2):388-396. PubMed ID: 34669935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults.
    Flores YN; Velázquez-Cruz R; Ramírez P; Bañuelos M; Zhang ZF; Yee HF; Chang SC; Canizales-Quinteros S; Quiterio M; Cabrera-Alvarez G; Patiño N; Salmerón J
    Mol Biol Rep; 2016 Dec; 43(12):1359-1369. PubMed ID: 27752939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of PNPLA3 rs738409 Genetic Polymorphism and Weight Gain ≥10 kg after Age 20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese Individuals.
    Nishioji K; Mochizuki N; Kobayashi M; Kamaguchi M; Sumida Y; Nishimura T; Yamaguchi K; Kadotani H; Itoh Y
    PLoS One; 2015; 10(10):e0140427. PubMed ID: 26485523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.
    Kantartzis K; Peter A; Machicao F; Machann J; Wagner S; Königsrainer I; Königsrainer A; Schick F; Fritsche A; Häring HU; Stefan N
    Diabetes; 2009 Nov; 58(11):2616-23. PubMed ID: 19651814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.
    Rotman Y; Koh C; Zmuda JM; Kleiner DE; Liang TJ;
    Hepatology; 2010 Sep; 52(3):894-903. PubMed ID: 20684021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical activity and sedentary behavior can modulate the effect of the PNPLA3 variant on childhood NAFLD: a case-control study in a Chinese population.
    Wang S; Song J; Shang X; Chawla N; Yang Y; Meng X; Wang H; Ma J
    BMC Med Genet; 2016 Dec; 17(1):90. PubMed ID: 27905898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the I148M/PNPLA3 (rs738409) polymorphism with premature coronary artery disease, fatty liver, and insulin resistance in type 2 diabetic patients and healthy controls. The GEA study.
    Posadas-Sánchez R; López-Uribe ÁR; Posadas-Romero C; Pérez-Hernández N; Rodríguez-Pérez JM; Ocampo-Arcos WA; Fragoso JM; Cardoso-Saldaña G; Vargas-Alarcón G
    Immunobiology; 2017 Oct; 222(10):960-966. PubMed ID: 27615511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals.
    Lin YC; Chang PF; Chang MH; Ni YH
    Am J Clin Nutr; 2014 Apr; 99(4):869-74. PubMed ID: 24477042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease.
    Grimaudo S; Pipitone RM; Pennisi G; Celsa C; Cammà C; Di Marco V; Barcellona MR; Boemi R; Enea M; Giannetti A; Spatola F; Marchesini G; Craxì A; Petta S
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):935-944.e3. PubMed ID: 31419571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.
    Nakamura M; Kanda T; Nakamoto S; Miyamura T; Jiang X; Wu S; Yokosuka O
    PLoS One; 2013; 8(12):e81312. PubMed ID: 24349054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of metabolic syndrome and patatin-like phospholipase 3 - rs738409 gene variant in non-alcoholic fatty liver disease among a Chennai-based south Indian population.
    Narayanasamy K; Karthick R; Panneerselvam P; Mohan N; Ramachandran A; Prakash R; Rajaram M
    J Gene Med; 2020 Apr; 22(4):e3160. PubMed ID: 31945251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
    Valenti L; Alisi A; Galmozzi E; Bartuli A; Del Menico B; Alterio A; Dongiovanni P; Fargion S; Nobili V
    Hepatology; 2010 Oct; 52(4):1274-80. PubMed ID: 20648474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
    Valenti L; Maggioni P; Piperno A; Rametta R; Pelucchi S; Mariani R; Dongiovanni P; Fracanzani AL; Fargion S
    World J Gastroenterol; 2012 Jun; 18(22):2813-20. PubMed ID: 22719190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: a meta-analysis.
    Zhang L; You W; Zhang H; Peng R; Zhu Q; Yao A; Li X; Zhou Y; Wang X; Pu L; Wu J
    J Gastroenterol Hepatol; 2015 May; 30(5):821-9. PubMed ID: 25641744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease.
    Shen J; Wong GL; Chan HL; Chan RS; Chan HY; Chu WC; Cheung BH; Yeung DK; Li LS; Sea MM; Woo J; Wong VW
    J Gastroenterol Hepatol; 2015 Jan; 30(1):139-46. PubMed ID: 25040896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PNPLA3 polymorphisms and liver aminotransferase levels in a Mexican American population.
    Li Q; Qu HQ; Rentfro AR; Grove ML; Mirza S; Lu Y; Hanis CL; Fallon MB; Boerwinkle E; Fisher-Hoch SP; McCormick JB
    Clin Invest Med; 2012 Aug; 35(4):E237-45. PubMed ID: 22863562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat.
    Giudice EM; Grandone A; Cirillo G; Santoro N; Amato A; Brienza C; Savarese P; Marzuillo P; Perrone L
    PLoS One; 2011; 6(11):e27933. PubMed ID: 22140488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship among GNB3 rs5443, PNPLA3 rs738409, GCKR rs780094 gene polymorphisms, type of maternal gestational weight gain and neonatal outcomes (STROBE-compliant article).
    Mărginean C; Mărginean CO; Bănescu C; Meliţ LE; Tripon F; Iancu M
    Medicine (Baltimore); 2019 Jul; 98(28):e16414. PubMed ID: 31305457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PNPLA3 I148M Polymorphism in Patients with Nonalcoholic Fatty Liver Disease, Obesity and Prediabetes.
    Karamfilova V; Gateva A; Assyov Y; Alexiev A; Savov A; Yaneva N; Ivanova I; Ivanova-Boyanova R; Ivanova R; Vlahova Z; Mateva L; Kamenov Z
    J Gastrointestin Liver Dis; 2019 Dec; 28(4):433-438. PubMed ID: 31826069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.